Reduction of >= 30% from baseline to the end of double-blind treatment on the total BEHAVE-AD score.
Change from baseline to the end of double-blind treatment in BEHAVE-AD global rating and total score; total CMAI score; CGI and CGI change from baseline; PSMS; safety evaluations conducted throughout the study.
55 Years and older (Adult, Senior)
November 15, 2005
December 3, 2010
† Study has passed its completion date and status has not been verified in more than two years.